Transcription_Factor

Size: px
Start display at page:

Download "Transcription_Factor"

Transcription

1 Transcription Factors 1216 個 (2012/4/1 現在 ) 遺伝子シンボル説明 FXC_PID 価格 FHC_PID 価格 AATF apoptosis antagonizing transcription factor FXC ,000 FHC ,000 ABT1 activator of basal transcription 1 FXC ,000 FHC ,000 AEBP2 AE binding protein 2, transcript variant 2 FXC30523M 90,000 FHC30523M 100,000 AFF1 AF4/FMR2 family, member 1 FXC ,000 FHC ,000 AFF4 AF4/FMR2 family, member 4 FXC07632M 50,000 FHC ,000 AHR aryl hydrocarbon receptor FXC ,000 FHC ,000 AHRR aryl-hydrocarbon receptor repressor FXC ,000 FHC ,000 ALX1 ALX homeobox 1 FXC24829M 50,000 FHC ,000 ALX4 ALX homeobox 4 FXC ,000 FHC ,000 ANP32A acidic (leucine-rich) nuclear phosphoprotein 32 family, FXC ,000 FHC ,000 AR Androgen receptor (Dihydrotestosterone receptor)(nuclear receptor subfamily 3 group C member 4) FXC11949M 50,000 FHC ,000 AR Androgen receptor (Dihydrotestosterone receptor)(nuclear receptor subfamily 3 group C member 4) FXC11950M 50,000 FHC ,000 AR androgen receptor FXC11031M 50,000 FHC ,000 ARID1B AT rich interactive domain 1B (SWI1-like) FXC11963M 140,000 FHC11963M 150,000 ARID3A AT rich interactive domain 3A (BRIGHT-like) FXC11107M 50,000 FHC ,000 ARID5B AT rich interactive domain 5B (MRF1-like) FXC ,000 FHC ,000 ARNT aryl hydrocarbon receptor nuclear translocator FXC ,000 FHC ,000 ARNT2 aryl-hydrocarbon receptor nuclear translocator 2 FXC ,000 FHC ,000 ARNTL Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Brain and muscle ARNT-like 1)(Member of PAS protein FXC ,000 FHC ,000 3)(Basic-helix-loop-helix-PAS protein MOP3)(bHLH-PAS ARNTL2 aryl hydrocarbon receptor nuclear translocator-like 2 FXC12305M 50,000 FHC ,000 ASCL1 achaete-scute complex homolog 1 (Drosophila) FXC ,000 FHC ,000 ASCL2 achaete-scute complex homolog 2 (Drosophila) FXC24115M 50,000 FHC ,000 ASCL3 achaete-scute complex homolog 3 (Drosophila) FXC ,000 FHC ,000 ASH1L ash1 (absent, small, or homeotic)-like (Drosophila) FXC12494M 50,000 FHC ,000 ASH2L ash2 (absent, small, or homeotic)-like (Drosophila) FXC ,000 FHC ,000 ATF1 activating transcription factor 1 FXC10950M 50,000 FHC ,000 ATF2 activating transcription factor 2 FXC ,000 FHC ,000 ATF3 Cyclic AMP-dependent transcription factor ATF-3 (campdependent transcription factor ATF-3)(Activating transcription FXC ,000 FHC ,000 factor 3) ATF4 activating transcription factor 4 (tax-responsive enhancer element B67) FXC ,000 FHC ,000 ATF5 activating transcription factor 5 FXC ,000 FHC ,000 ATF6 activating transcription factor 6 FXC20682M 90,000 FHC20682M 100,000 ATF7 activating transcription factor 7 FXC ,000 FHC ,000 ATOH1 atonal homolog 1 (Drosophila) FXC ,000 FHC ,000 ATOH8 atonal homolog 8 (Drosophila) FXC ,000 FHC ,000 ATRX alpha thalassemia/mental retardation syndrome X-linked, transcript variant 1 FXC12303M 150,000 FHC12303M 160,000 BACH1 BTB and CNC homology 1, basic leucine zipper transcription factor 1 FXC ,000 FHC ,000 BACH2 BTB and CNC homology 1, basic leucine zipper transcription factor 2 FXC ,000 FHC ,000 BANP BTG3 associated nuclear protein FXC09951M 50,000 FHC ,000 BARHL1 BarH-like homeobox 1 FXC ,000 FHC ,000 BARHL2 BarH-like homeobox 2 FXC20405M 50,000 FHC ,000 BARX2 Homeobox protein BarH-like 2 FXC ,000 FHC ,000 BATF basic leucine zipper transcription factor, ATF-like FXC ,000 FHC ,000 BATF3 basic leucine zipper transcription factor, ATF-like 3 FXC ,000 FHC ,000 BAZ2A bromodomain adjacent to zinc finger domain, 2A FXC ,000 FHC ,000 BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) FXC ,000 FHC ,000 BCL6 B-cell CLL/lymphoma 6 FXC ,000 FHC ,000 BCL6B B-cell CLL/lymphoma 6, member B (zinc finger protein) FXC ,000 FHC ,000 BCLAF1 BCL2-associated transcription factor 1 FXC ,000 FHC ,000 BLZF1 basic leucine zipper nuclear factor 1 FXC ,000 FHC ,000 BMI1 BMI1 polycomb ring finger oncogene FXC ,000 FHC ,000 BNC1 basonuclin 1 FXC04279M 50,000 FHC ,000 BRD1 bromodomain containing 1 FXC ,000 FHC ,000 BRD2 bromodomain containing 2 FXC ,000 FHC ,000 BRD3 bromodomain containing 3 FXC ,000 FHC ,000 BRD4 Bromodomain-containing protein 4 FXC11882M 50,000 FHC ,000 BRD7 Bromodomain-containing protein 7 (75 kda bromodomain protein)(protein CELTIX-1) FXC ,000 FHC ,000 BRDT bromodomain, testis-specific FXC ,000 FHC ,000

2 BRF1 Transcription factor IIIB 90 kda subunit (TFIIIB90)(hTFIIIB90)(B-related factor 1)(BRF- FXC ,000 FHC ,000 1)(hBRF)(TATA box-binding protein-associated factor, RNA BRF2 Transcription factor IIIB 50 kda subunit (TFIIIB50)(hTFIIIB50)(B-related factor 2)(BRF-2)(hBRFU) FXC ,000 FHC ,000 BRPF1 bromodomain and PHD finger containing, 1 FXC ,000 FHC ,000 BRPF3 bromodomain and PHD finger containing, 3 FXC ,000 FHC ,000 BTBD1 BTB (POZ) domain containing 1 FXC ,000 FHC ,000 BTBD2 BTB (POZ) domain containing 2 FXC ,000 FHC ,000 BTBD3 BTB (POZ) domain containing 3 FXC ,000 FHC ,000 BTBD6 BTB (POZ) domain containing 6 FXC31515M 50,000 FHC ,000 BTF3 basic transcription factor 3 FXC ,000 FHC ,000 C11orf9 chromosome 11 open reading frame 9 FXC ,000 FHC ,000 CAND1 cullin-associated and neddylation-dissociated 1 FXC ,000 FHC ,000 CBFA2T2 Protein CBFA2T2 (MTG8-related protein 1)(MTG8-like protein)(myeloid translocation-related protein 1)(ETO FXC ,000 FHC ,000 homologous on chromosome 20)(p85) CBFA2T3 Protein CBFA2T3 (Myeloid translocation gene on chromosome 16 protein)(hmtg16)(mtg8-related protein FXC ,000 FHC ,000 2)(Zinc finger MYND domain-containing protein 4) CBX1 Chromobox protein homolog 1 (Heterochromatin protein 1 homolog beta)(hp1 beta)(modifier 1 FXC ,000 FHC ,000 protein)(m31)(heterochromatin protein CBX2 chromobox homolog 2 (Pc class homolog, Drosophila) FXC ,000 FHC ,000 CBX3 chromobox homolog 3 (HP1 gamma homolog, Drosophila) FXC ,000 FHC ,000 CBX4 chromobox homolog 4 (Pc class homolog, Drosophila) FXC ,000 FHC ,000 CBX5 chromobox homolog 5 (HP1 alpha homolog, Drosophila) FXC ,000 FHC ,000 CBX7 chromobox homolog 7 FXC ,000 FHC ,000 CBX8 chromobox homolog 8 (Pc class homolog, Drosophila) FXC ,000 FHC ,000 CDX1 caudal type homeobox 1 FXC ,000 FHC ,000 CDX2 caudal type homeobox 2 FXC ,000 FHC ,000 CDX4 caudal type homeobox 4 FXC27424M 50,000 FHC ,000 CEBPA CCAAT/enhancer-binding protein alpha FXC10825M 50,000 FHC ,000 CEBPB CCAAT/enhancer binding protein (C/EBP), beta FXC ,000 FHC ,000 CEBPD CCAAT/enhancer binding protein (C/EBP), delta FXC23262M 50,000 FHC ,000 CEBPE CCAAT/enhancer-binding protein epsilon (C/EBP epsilon) FXC ,000 FHC ,000 CEBPG CCAAT/enhancer binding protein (C/EBP), gamma FXC ,000 FHC ,000 CENPH centromere protein H FXC08778M 50,000 FHC ,000 CHD2 chromodomain helicase DNA binding protein 2 FXC31523M 50,000 FHC ,000 CHD4 chromodomain helicase DNA binding protein 4 FXC11086M 50,000 FHC ,000 CHD5 Chromodomain-helicase-DNA-binding protein 5 FXC ,000 FHC ,000 CHD6 chromodomain helicase DNA binding protein 6 FXC11090M 50,000 FHC ,000 CIAO1 cytosolic iron-sulfur protein assembly 1 homolog (S. FXC ,000 FHC ,000 CIC capicua homolog (Drosophila) FXC ,000 FHC ,000 CIITA class II, major histocompatibility complex, transactivator FXC25588M 100,000 FHC25588M 110,000 CITED1 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 FXC ,000 FHC ,000 CITED2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 FXC ,000 FHC ,000 CLOCK clock homolog (mouse) FXC ,000 FHC ,000 CNBP CCHC-type zinc finger, nucleic acid binding protein FXC ,000 FHC ,000 CNOT3 CCR4-NOT transcription complex, subunit 3 FXC ,000 FHC ,000 CNOT4 CCR4-NOT transcription complex, subunit 4 FXC ,000 FHC ,000 CNOT8 CCR4-NOT transcription complex, subunit 8 FXC ,000 FHC ,000 COPS2 COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis) FXC ,000 FHC ,000 COPS5 COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis) FXC ,000 FHC ,000 CREB1 camp responsive element binding protein 1 FXC ,000 FHC ,000 CREB3 camp responsive element binding protein 3 FXC ,000 FHC ,000 CREB3L1 camp responsive element binding protein 3-like 1 FXC ,000 FHC ,000 CREB3L2 camp responsive element binding protein 3-like 2 FXC ,000 FHC ,000 CREB3L3 camp responsive element binding protein 3-like 3 FXC26402M 50,000 FHC ,000 CREB3L4 Cyclic AMP-responsive element-binding protein 3-like protein 4 (camp-responsive element-binding protein 3-like protein 4)(Cyclic AMP-responsive element-binding protein 4)(cAMPresponsive element-binding protein 4)(CREB-4)(Androgeninduced basic leucine zipper protein)(aibzip)(attaching to CRE-like 1)(ATCE1)(Transcript induced in spermiogenesis protein 40)(Tisp40)(hJAL) [Contains Processed cyclic AMPresponsive element-binding protein 3-like protein 4] FXC ,000 FHC ,000

3 CREBBP CREB-binding protein FXC11778M 110,000 FHC11778M 120,000 CREBL2 camp responsive element binding protein-like 2 FXC ,000 FHC ,000 CREBZF CREB/ATF bzip transcription factor FXC ,000 FHC ,000 CREG1 cellular repressor of E1A-stimulated genes 1 FXC ,000 FHC ,000 CREM camp responsive element modulator FXC10995M 50,000 FHC ,000 CRIP2 Cysteine-rich protein 2 (CRP2)(Protein ESP1) FXC ,000 FHC ,000 CRX cone-rod homeobox FXC ,000 FHC ,000 CSDA cold shock domain protein A FXC04649M 50,000 FHC ,000 CSRP1 Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1)(CRP1)(CRP) FXC ,000 FHC ,000 CSRP2 Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2)(CRP2)(Smooth muscle cell LIM protein)(smlim)(lim FXC ,000 FHC ,000 domain only protein 5) CSRP3 Cysteine and glycine-rich protein 3 (Cysteine-rich protein 3)(CRP3)(LIM domain protein, cardiac)(muscle LIM protein) FXC ,000 FHC ,000 CTCF CCCTC-binding factor (zinc finger protein) FXC ,000 FHC ,000 CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa FXC ,000 FHC ,000 DCP1A DCP1 decapping enzyme homolog A (S. cerevisiae) FXC08327M 50,000 FHC ,000 DDIT3 DNA damage-inducible transcript 3 (DDIT-3)(Growth arrest and DNA-damage-inducible protein GADD153)(C/EBPhomologous FXC ,000 FHC ,000 protein)(chop) DEAF1 deformed epidermal autoregulatory factor 1 (Drosophila) FXC ,000 FHC ,000 DIDO1 death inducer-obliterator 1 FXC ,000 FHC ,000 DLX1 Homeobox protein DLX-1 FXC ,000 FHC ,000 DLX2 distal-less homeobox 2 FXC11120M 50,000 FHC ,000 DLX3 distal-less homeobox 3 FXC ,000 FHC ,000 DLX4 Homeobox protein DLX-4 (DLX-7)(DLX-8)(Beta protein 1) FXC ,000 FHC ,000 DLX5 distal-less homeobox 5 FXC ,000 FHC ,000 DMBX1 Diencephalon/mesencephalon homeobox protein 1 (Pairedlike homeobox protein DMBX1)(Orthodenticle homolog 3) FXC ,000 FHC ,000 DMRT1 doublesex and mab-3 related transcription factor 1 FXC ,000 FHC ,000 DMRT2 doublesex and mab-3 related transcription factor 2 FXC ,000 FHC ,000 DMRTA1 DMRT-like family A1 FXC ,000 FHC ,000 DMRTB1 DMRT-like family B with proline-rich C-terminal, 1 FXC20313M 50,000 FHC ,000 DMRTC1 Doublesex- and mab-3-related transcription factor C1 FXC ,000 FHC ,000 DMRTC2 DMRT-like family C2 FXC ,000 FHC ,000 DPF1 D4, zinc and double PHD fingers family 1 FXC ,000 FHC ,000 DPF2 D4, zinc and double PHD fingers family 2 FXC ,000 FHC ,000 DR1 down-regulator of transcription 1, TBP-binding (negative cofactor 2) FXC ,000 FHC ,000 DRAP1 DR1-associated protein 1 (negative cofactor 2 alpha) FXC ,000 FHC ,000 DUX1 double homeobox, 1 FXC ,000 FHC ,000 DUX3 double homeobox, 3 FXC ,000 FHC ,000 E2F1 E2F transcription factor 1 FXC26966M 50,000 FHC ,000 E2F2 E2F transcription factor 2 FXC ,000 FHC ,000 E2F4 E2F transcription factor 4, p107/p130-binding FXC09474M 50,000 FHC ,000 E2F5 E2F transcription factor 5, p130-binding FXC10985M 50,000 FHC ,000 E2F6 E2F transcription factor 6 FXC ,000 FHC ,000 EBF1 Transcription factor COE1 (O/E-1)(OE-1)(Early B-cell factor) FXC ,000 FHC ,000 EBF2 early B-cell factor 2 FXC ,000 FHC ,000 EBF4 early B-cell factor 4 FXC ,000 FHC ,000 ECD Protein SGT1 (hsgt1)(protein ecdysoneless homolog)(suppressor of GCR2) FXC ,000 FHC ,000 EED embryonic ectoderm development FXC ,000 FHC ,000 EED embryonic ectoderm development FXC11996M 90,000 FHC11996M 100,000 EGLN2 Egl nine homolog 2 (EC )(Hypoxia-inducible factor prolyl hydroxylase 1)(HIF-prolyl hydroxylase 1)(HIF- PH1)(HPH-3)(Prolyl hydroxylase domain-containing protein FXC ,000 FHC ,000 1)(PHD1)(Estrogen-induced tag 6) EGLN3 egl nine homolog 3 (C. elegans) FXC ,000 FHC ,000 EGR1 early growth response 1 FXC31400M 50,000 FHC ,000 EGR2 Early growth response protein 2 FXC ,000 FHC ,000 EGR3 early growth response 3 FXC ,000 FHC ,000 EGR4 early growth response 4 FXC ,000 FHC ,000 EHF ets homologous factor FXC24200M 50,000 FHC ,000 ELF1 ETS-related transcription factor Elf-1 (E74-like factor 1) FXC ,000 FHC ,000 ELF3 ETS-related transcription factor Elf-3 (E74-like factor 3)(Epithelium-specific Ets transcription factor 1)(ESE- FXC ,000 FHC ,000 1)(Epithelium-restricted Ets protein ESX)(Epithelial-restricted ELF4 ETS-related transcription factor Elf-4 (E74-like factor 4)(Myeloid Elf-1-like factor) FXC ,000 FHC ,000

4 ELF5 ETS-related transcription factor Elf-5 (E74-like factor 5)(Epithelium-specific Ets transcription factor 2)(ESE- FXC ,000 FHC ,000 2)(Epithelium-restricted ESE-1-related Ets factor) ELK1 ELK1, member of ETS oncogene family FXC ,000 FHC ,000 ELK3 ELK3, ETS-domain protein (SRF accessory protein 2) FXC ,000 FHC ,000 ELK4 ELK4, ETS-domain protein (SRF accessory protein 1), transcript variant a FXC20788M 50,000 FHC ,000 EMX1 empty spiracles homeobox 1 FXC ,000 FHC ,000 EMX2 empty spiracles homeobox 2 FXC ,000 FHC ,000 EN1 engrailed homeobox 1 FXC04893M 50,000 FHC ,000 ENC1 ectodermal-neural cortex (with BTB-like domain) FXC10803M 50,000 FHC ,000 ENO1 enolase 1, (alpha) FXC ,000 FHC ,000 EOMES eomesodermin homolog (Xenopus laevis) FXC ,000 FHC ,000 EP300 E1A binding protein p300 FXC ,000 FHC ,000 EP400 E1A binding protein p400 FXC ,000 FHC ,000 EPAS1 endothelial PAS domain protein 1 FXC ,000 FHC ,000 ERCC2 excision repair cross-complementing rodent repair deficiency, complementation group 2 FXC28644M 50,000 FHC ,000 ERCC3 excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B FXC ,000 FHC ,000 complementing) ERF Ets2 repressor factor FXC ,000 FHC ,000 ERG v-ets erythroblastosis virus E26 oncogene homolog (avian) FXC ,000 FHC ,000 ESR1 Estrogen receptor (ER)(Estradiol receptor)(er-alpha)(nuclear receptor subfamily 3 group A member 1) FXC ,000 FHC ,000 ESRRA estrogen-related receptor alpha FXC ,000 FHC ,000 ESRRB estrogen-related receptor beta FXC ,000 FHC ,000 ESRRG estrogen-related receptor gamma FXC ,000 FHC ,000 ETS1 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) FXC ,000 FHC ,000 ETS2 Protein C-ets-2 FXC ,000 FHC ,000 ETV1 ets variant 1 FXC ,000 FHC ,000 ETV2 ets variant 2 FXC ,000 FHC ,000 ETV3 ETS translocation variant 3 (ETS domain transcriptional repressor PE1)(PE-1)(Mitogenic Ets transcriptional FXC ,000 FHC ,000 ETV4 ets variant 4 FXC ,000 FHC ,000 ETV5 ets variant 5 FXC ,000 FHC ,000 ETV6 ets variant 6 FXC ,000 FHC ,000 ETV7 ets variant 7 FXC ,000 FHC ,000 EVX1 even-skipped homeobox 1 FXC22886M 50,000 FHC ,000 EZH1 enhancer of zeste homolog 1 (Drosophila) FXC ,000 FHC ,000 EZH2 Histone-lysine N-methyltransferase EZH2 (EC )(Enhancer of zeste homolog 2)(ENX-1)(Lysine N- FXC08523M 50,000 FHC ,000 FAM48A Protein FAM48A (p38-interacting protein)(p38ip) FXC09339M 50,000 FHC ,000 FHL2 four and a half LIM domains 2 FXC08734M 50,000 FHC ,000 FHL5 Four and a half LIM domains protein 5 (FHL-5)(Activator of camp-responsive element modulator in testis)(activator of FXC ,000 FHC ,000 CREM in testis) FIZ1 FLT3-interacting zinc finger 1 FXC31590M 50,000 FHC ,000 FLI1 Friend leukemia virus integration 1 FXC ,000 FHC ,000 FOS v-fos FBJ murine osteosarcoma viral oncogene homolog FXC ,000 FHC ,000 FOSB FBJ murine osteosarcoma viral oncogene homolog B FXC ,000 FHC ,000 FOSL1 FOS-like antigen 1 FXC ,000 FHC ,000 FOSL2 Fos-related antigen 2 FXC ,000 FHC ,000 FOXA1 forkhead box A1 FXC ,000 FHC ,000 FOXA2 forkhead box A2 FXC ,000 FHC ,000 FOXA3 forkhead box A3 FXC ,000 FHC ,000 FOXB1 forkhead box B1 FXC ,000 FHC ,000 FOXC2 forkhead box C2 (MFH-1, mesenchyme forkhead 1) FXC05223M 50,000 FHC ,000 FOXD3 forkhead box D3 FXC ,000 FHC ,000 FOXD4 forkhead box D4 FXC ,000 FHC ,000 FOXE1 forkhead box E1 (thyroid transcription factor 2) FXC ,000 FHC ,000 FOXF1 forkhead box F1 FXC ,000 FHC ,000 FOXF2 forkhead box F2 FXC ,000 FHC ,000 FOXH1 forkhead box H1 FXC ,000 FHC ,000 FOXI1 forkhead box I1 FXC ,000 FHC ,000 FOXJ1 forkhead box J1 FXC ,000 FHC ,000 FOXJ2 forkhead box J2 FXC ,000 FHC ,000 FOXJ3 forkhead box J3 FXC ,000 FHC ,000 FOXL1 forkhead box L1 FXC ,000 FHC ,000

5 FOXM1 Forkhead box protein M1 (Forkhead-related protein FKHL16)(Hepatocyte nuclear factor 3 forkhead homolog 11)(HNF-3/fork-head homolog 11)(HFH-11)(Winged-helix FXC ,000 FHC ,000 factor from INS-1 cells)(m-phase phosphoprotein 2)(MPM-2 reactive phosphoprotein 2)(Transcription factor Trident) FOXN1 forkhead box N1 FXC05225M 50,000 FHC ,000 FOXN2 Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FXC ,000 FHC ,000 FOXN3 Forkhead box protein N3 (Checkpoint suppressor 1) FXC ,000 FHC ,000 FOXN4 forkhead box N4 FXC ,000 FHC ,000 FOXO3 forkhead box O3 FXC22719M 50,000 FHC ,000 FOXO4 forkhead box O4 FXC ,000 FHC ,000 FOXP1 Forkhead box protein P1 FXC ,000 FHC ,000 FOXP3 forkhead box P3 FXC ,000 FHC ,000 FOXP4 Forkhead box protein P4 (Fork head-related protein-like A) FXC ,000 FHC ,000 GABPA GA binding protein transcription factor, alpha subunit 60kDa FXC ,000 FHC ,000 GABPB1 GA-binding protein subunit beta-1 (GABP subunit beta- 1)(GABPB-1)(GABP subunit beta-2)(gabpb-2)(transcription FXC ,000 FHC ,000 factor E4TF1-53)(Transcription factor E4TF1-47)(Nuclear GABPB2 GA-binding protein subunit beta-2 FXC ,000 FHC ,000 GATA1 GATA binding protein 1 (globin transcription factor 1) FXC ,000 FHC ,000 GATA2 GATA binding protein 2 FXC ,000 FHC ,000 GATA3 GATA binding protein 3 FXC ,000 FHC ,000 GATA4 GATA binding protein 4 FXC ,000 FHC ,000 GBX2 gastrulation brain homeobox 2 FXC ,000 FHC ,000 GCM1 glial cells missing homolog 1 (Drosophila) FXC22660M 50,000 FHC ,000 GFI1 growth factor independent 1 transcription repressor FXC ,000 FHC ,000 GFI1B Zinc finger protein Gfi-1b (Growth factor independent protein 1B)(Potential regulator of CDKN1A translocated in CML) FXC ,000 FHC ,000 GLI1 GLI family zinc finger 1 FXC ,000 FHC ,000 GLI2 GLI family zinc finger 2 FXC ,000 FHC ,000 GLI3 GLI family zinc finger 3 FXC ,000 FHC ,000 GLI4 Zinc finger protein 41 homolog (Zfp-41) FXC08726M 50,000 FHC ,000 GLIS1 GLIS family zinc finger 1 FXC20314M 50,000 FHC ,000 GLIS2 GLIS family zinc finger 2 FXC ,000 FHC ,000 GRHL2 Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead)(transcription factor CP2-like 3) FXC ,000 FHC ,000 GSC Homeobox protein goosecoid FXC ,000 FHC ,000 GSX1 GS homeobox 1 FXC ,000 FHC ,000 GSX2 GS homeobox 2 FXC ,000 FHC ,000 GTF2A1 Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1)(TFIIA-42)(TFIIAL) [Contains Transcription initiation factor IIA alpha chain(tfiia p35 FXC ,000 FHC ,000 subunit);transcription initiation factor IIA beta chain(tfiia p19 GTF2A1L general transcription factor IIA, 1-like FXC11049M 50,000 FHC ,000 GTF2A2 general transcription factor IIA, 2, 12kDa FXC ,000 FHC ,000 GTF2B Transcription initiation factor IIB (General transcription factor TFIIB)(S300-II) FXC ,000 FHC ,000 GTF2E1 general transcription factor IIE, polypeptide 1, alpha 56kDa FXC ,000 FHC ,000 GTF2E2 general transcription factor IIE, polypeptide 2, beta 34kDa FXC ,000 FHC ,000 GTF2F1 general transcription factor IIF, polypeptide 1, 74kDa FXC ,000 FHC ,000 GTF2F2 General transcription factor IIF subunit 2 (EC )(Transcription initiation factor IIF subunit beta)(tfiifbeta)(atp-dependent FXC ,000 FHC ,000 helicase GTF2F2)(Transcription GTF2H1 general transcription factor IIH, polypeptide 1, 62kDa FXC ,000 FHC ,000 GTF2H2 general transcription factor IIH, polypeptide 2, 44kDa FXC ,000 FHC ,000 GTF2H3 general transcription factor IIH, polypeptide 3, 34kDa FXC ,000 FHC ,000 GTF2H4 general transcription factor IIH, polypeptide 4, 52kDa FXC09855M 50,000 FHC ,000 GTF2I general transcription factor II, i FXC ,000 FHC ,000 GTF2IRD1 General transcription factor II-I repeat domain-containing protein 1 (GTF2I repeat domain-containing protein 1)(Muscle TFII-I repeat domain-containing protein 1)(General transcription factor III)(Slow-muscle-fiber enhancer-binding FXC ,000 FHC ,000 protein)(use B1-binding protein)(mustrd1/ben)(williams- Beuren syndrome chromosomal region 11 protein) GTF2IRD2 General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein FXC ,000 FHC ,000 2A)(Transcription factor GTF2IRD2-alpha) GTF3A general transcription factor IIIA FXC10865M 50,000 FHC ,000 GTF3C1 general transcription factor IIIC, polypeptide 1, alpha 220kDa FXC28375M 50,000 FHC ,000 GTF3C2 general transcription factor IIIC, polypeptide 2, beta 110kDa FXC ,000 FHC ,000

6 GTF3C3 general transcription factor IIIC, polypeptide 3, 102kDa FXC ,000 FHC ,000 GTF3C4 General transcription factor 3C polypeptide 4 (EC )(Transcription factor IIIC subunit delta)(tf3cdelta)(tfiiic FXC ,000 FHC , kda subunit)(tfiiic 90) GTF3C5 general transcription factor IIIC, polypeptide 5, 63kDa FXC08546M 50,000 FHC ,000 GZF1 GDNF-inducible zinc finger protein 1 FXC ,000 FHC ,000 HAND1 heart and neural crest derivatives expressed 1 FXC ,000 FHC ,000 HAND2 heart and neural crest derivatives expressed 2 FXC ,000 FHC ,000 HDAC1 histone deacetylase 1 FXC ,000 FHC ,000 HDAC2 Histone deacetylase 2 (HD2)(EC ) FXC05328M 50,000 FHC ,000 HDAC2 histone deacetylase 2 FXC31712M 90,000 FHC31712M 100,000 HDAC4 histone deacetylase 4 FXC ,000 FHC ,000 HDAC8 Histone deacetylase 8 (HD8)(EC ) FXC ,000 FHC ,000 HES1 Transcription factor HES-1 (Hairy and enhancer of split 1)(Hairy-like)(HHL)(Hairy homolog) FXC ,000 FHC ,000 HES2 hairy and enhancer of split 2 (Drosophila) FXC ,000 FHC ,000 HES6 hairy and enhancer of split 6 (Drosophila) FXC ,000 FHC ,000 HES7 hairy and enhancer of split 7 (Drosophila) FXC ,000 FHC ,000 HESX1 Homeobox expressed in ES cells 1 (Homeobox protein ANF)(hAnf) FXC ,000 FHC ,000 HEXIM1 hexamethylene bis-acetamide inducible 1 FXC ,000 FHC ,000 HEY1 hairy/enhancer-of-split related with YRPW motif 1 FXC ,000 FHC ,000 HEY2 hairy/enhancer-of-split related with YRPW motif 2 FXC ,000 FHC ,000 HEYL hairy/enhancer-of-split related with YRPW motif-like FXC ,000 FHC ,000 HHEX Hematopoietically-expressed homeobox protein HHEX (Homeobox protein HEX)(Homeobox protein PRH) FXC ,000 FHC ,000 HIC1 hypermethylated in cancer 1 FXC11001M 50,000 FHC ,000 HIC2 hypermethylated in cancer 2 FXC ,000 FHC ,000 HIF1A hypoxia inducible factor 1, alpha subunit (basic helix-loophelix transcription factor) FXC ,000 FHC ,000 HIF3A Hypoxia-inducible factor 3 alpha (HIF-3 alpha)(hif3 alpha 1)(Member of PAS protein 7)(Basic-helix-loop-helix-PAS FXC ,000 FHC ,000 protein MOP7)(Inhibitory PAS domain protein)(ipas) HIRA HIR histone cell cycle regulation defective homolog A (S. cerevisiae) FXC ,000 FHC ,000 HIVEP1 human immunodeficiency virus type I enhancer binding FXC ,000 FHC ,000 HIVEP2 human immunodeficiency virus type I enhancer binding FXC ,000 FHC ,000 HIVEP3 human immunodeficiency virus type I enhancer binding FXC ,000 FHC ,000 HLF Hepatic leukemia factor FXC ,000 FHC ,000 HLTF helicase-like transcription factor FXC28939M 50,000 FHC ,000 HLX H2.0-like homeobox FXC ,000 FHC ,000 HMG20A high-mobility group 20A FXC ,000 FHC ,000 HMG20B high mobility group 20B FXC30780M 50,000 FHC ,000 HMGA1 high mobility group AT-hook 1 FXC08399M 50,000 FHC ,000 HMGA2 high mobility group AT-hook 2 FXC28157M 50,000 FHC ,000 HMGB1 High mobility group protein B1 (High mobility group protein 1)(HMG-1) FXC ,000 FHC ,000 HMGB2 high-mobility group box 2 FXC ,000 FHC ,000 HMGN2 high-mobility group nucleosomal binding domain 2 FXC ,000 FHC ,000 HMX2 H6 family homeobox 2 FXC27892M 50,000 FHC ,000 HNF1A Hepatocyte nuclear factor 1-alpha (HNF-1A)(Liver-specific transcription factor LF-B1)(LFB1)(Transcription factor 1)(TCF- FXC ,000 FHC ,000 HNF1B Hepatocyte nuclear factor 1-beta (HNF-1-beta)(HNF- 1B)(Transcription factor 2)(TCF-2)(Variant hepatic nuclear FXC ,000 FHC ,000 factor 1)(vHNF1)(Homeoprotein LFB3) HNF4A hepatocyte nuclear factor 4, alpha FXC ,000 FHC ,000 HNF4G hepatocyte nuclear factor 4, gamma FXC23316M 50,000 FHC ,000 HOXA1 homeobox A1 FXC ,000 FHC ,000 HOXA10 homeobox A10 FXC ,000 FHC ,000 HOXA11 homeobox A11 FXC ,000 FHC ,000 HOXA2 homeobox A2 FXC ,000 FHC ,000 HOXA3 homeobox A3 FXC ,000 FHC ,000 HOXA4 homeobox A4 FXC ,000 FHC ,000 HOXA5 Homeobox protein Hox-A5 (Hox-1C) FXC ,000 FHC ,000 HOXA6 Homeobox protein Hox-A6 (Hox-1B) FXC ,000 FHC ,000 HOXA7 homeobox A7 FXC ,000 FHC ,000 HOXA9 homeobox A9 FXC ,000 FHC ,000 HOXB13 homeobox B13 FXC ,000 FHC ,000 HOXB2 homeobox B2 FXC26088M 50,000 FHC ,000 HOXB3 homeobox B3 FXC ,000 FHC ,000 HOXB4 homeobox B4 FXC26089M 50,000 FHC ,000

7 HOXB5 homeobox B5 FXC ,000 FHC ,000 HOXB6 homeobox B6 FXC ,000 FHC ,000 HOXB8 homeobox B8 FXC ,000 FHC ,000 HOXB9 homeobox B9 FXC ,000 FHC ,000 HOXC10 homeobox C10 FXC ,000 FHC ,000 HOXC11 homeobox C11 FXC24755M 50,000 FHC ,000 HOXC12 homeobox C12 FXC ,000 FHC ,000 HOXC4 homeobox C4 FXC ,000 FHC ,000 HOXC5 homeobox C5 FXC ,000 FHC ,000 HOXC6 Homeobox protein Hox-C6 (Hox-3C)(HHO.C8)(CP25) FXC ,000 FHC ,000 HOXC8 homeobox C8 FXC ,000 FHC ,000 HOXC9 homeobox C9 FXC ,000 FHC ,000 HOXD1 homeobox D1 FXC ,000 FHC ,000 HOXD10 homeobox D10 FXC ,000 FHC ,000 HOXD13 homeobox D13 FXC ,000 FHC ,000 HOXD3 homeobox D3 FXC ,000 FHC ,000 HOXD4 homeobox D4 FXC ,000 FHC ,000 HOXD8 homeobox D8 FXC ,000 FHC ,000 HOXD9 homeobox D9 FXC ,000 FHC ,000 HSF1 heat shock transcription factor 1 FXC ,000 FHC ,000 HSF2 heat shock transcription factor 2 FXC ,000 FHC ,000 HSF2BP heat shock transcription factor 2 binding protein FXC ,000 FHC ,000 HSF4 heat shock transcription factor 4 FXC ,000 FHC ,000 HSFX1 Heat shock transcription factor, X-linked FXC03998M 50,000 FHC ,000 ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein FXC ,000 FHC ,000 ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein FXC ,000 FHC ,000 ID2B Putative DNA-binding protein inhibitor ID-2B FXC ,000 FHC ,000 ID3 inhibitor of DNA binding 3, dominant negative helix-loop-helix protein FXC ,000 FHC ,000 IER2 immediate early response 2 FXC ,000 FHC ,000 IKZF1 IKAROS family zinc finger 1 (Ikaros) FXC ,000 FHC ,000 IKZF2 Zinc finger protein Helios (Ikaros family zinc finger protein 2) FXC ,000 FHC ,000 IKZF3 IKAROS family zinc finger 3 (Aiolos) FXC25999M 50,000 FHC ,000 IKZF4 IKAROS family zinc finger 4 (Eos) FXC ,000 FHC ,000 IKZF5 IKAROS family zinc finger 5 (Pegasus) FXC ,000 FHC ,000 ILF2 interleukin enhancer binding factor 2, 45kDa FXC ,000 FHC ,000 ILF3 Interleukin enhancer-binding factor 3 (Nuclear factor of activated T-cells 90 kda)(nf-at-90)(double-stranded RNAbinding protein 76)(DRBP76)(Translational control protein FXC ,000 FHC ,000 80)(TCP80)(Nuclear factor associated with dsrna)(nfar)(mphase phosphoprotein 4)(MPP4) IRF1 Interferon regulatory factor 1 (IRF-1) FXC ,000 FHC ,000 IRF2 interferon regulatory factor 2 FXC ,000 FHC ,000 IRF3 interferon regulatory factor 3 FXC ,000 FHC ,000 IRF4 interferon regulatory factor 4 FXC ,000 FHC ,000 IRF5 Interferon regulatory factor 5 (IRF-5) FXC ,000 FHC ,000 IRF6 interferon regulatory factor 6 FXC ,000 FHC ,000 IRF7 interferon regulatory factor 7 FXC ,000 FHC ,000 IRF8 interferon regulatory factor 8 FXC ,000 FHC ,000 IRF9 interferon regulatory factor 9 FXC25116M 50,000 FHC ,000 IRX4 Iroquois-class homeodomain protein IRX-4 (Iroquois homeobox protein 4)(Homeodomain protein IRXA3) FXC ,000 FHC ,000 IRX5 iroquois homeobox 5, transcript variant 1 FXC25701M 50,000 FHC ,000 IRX6 iroquois homeobox 6 FXC ,000 FHC ,000 ISL1 ISL LIM homeobox 1 FXC ,000 FHC ,000 IVNS1ABP influenza virus NS1A binding protein FXC ,000 FHC ,000 JARID2 jumonji, AT rich interactive domain 2 FXC11900M 50,000 FHC ,000 JDP2 Jun dimerization protein 2 FXC ,000 FHC ,000 JMJD4 jumonji domain containing 4 FXC ,000 FHC07769M 60,000 JUN jun oncogene FXC ,000 FHC ,000 JUNB jun B proto-oncogene FXC ,000 FHC ,000 JUND jun D proto-oncogene FXC28593M 50,000 FHC ,000 KAT2A General control of amino acid synthesis protein 5-like 2 (EC )(Histone acetyltransferase FXC ,000 FHC ,000 KBTBD10 kelch repeat and BTB (POZ) domain containing 10 FXC11059M 50,000 FHC ,000 KBTBD5 kelch repeat and BTB (POZ) domain containing 5 FXC21500M 50,000 FHC ,000 KBTBD7 kelch repeat and BTB (POZ) domain containing 7 FXC ,000 FHC ,000

8 KDM4D Lysine-specific demethylase 4D (EC )(JmjC domaincontaining histone demethylation protein 3D)(Jumonji domaincontaining FXC ,000 FHC ,000 protein 2D) KDM5B lysine (K)-specific demethylase 5B FXC27753M 50,000 FHC ,000 KDM5C lysine (K)-specific demethylase 5C FXC11536M 50,000 FHC ,000 KEAP1 kelch-like ECH-associated protein 1 FXC ,000 FHC ,000 KLF1 Kruppel-like factor 1 (erythroid) FXC ,000 FHC ,000 KLF10 Kruppel-like factor 10 FXC ,000 FHC ,000 KLF11 Kruppel-like factor 11 FXC ,000 FHC ,000 KLF12 Kruppel-like factor 12 FXC ,000 FHC ,000 KLF15 Kruppel-like factor 15 FXC ,000 FHC ,000 KLF16 Kruppel-like factor 16 FXC26377M 50,000 FHC ,000 KLF3 Kruppel-like factor 3 (basic) FXC ,000 FHC ,000 KLF4 Kruppel-like factor 4 (gut) FXC ,000 FHC ,000 KLF5 Kruppel-like factor 5 (intestinal) FXC09924M 50,000 FHC ,000 KLF6 Krueppel-like factor 6 (Core promoter element-binding protein)(b-cell-derived protein 1)(Proto-oncogene FXC ,000 FHC ,000 BCD1)(Transcription factor Zf9)(GC-rich sites-binding factor KLF7 Kruppel-like factor 7 (ubiquitous) FXC ,000 FHC ,000 KLF8 Kruppel-like factor 8 FXC ,000 FHC ,000 KLF9 Kruppel-like factor 9 FXC ,000 FHC ,000 KLHDC5 Kelch domain-containing protein 5 FXC ,000 FHC ,000 KLHL1 kelch-like 1 (Drosophila) FXC ,000 FHC ,000 KLHL12 Kelch-like protein 12 (CUL3-interacting protein 1) FXC ,000 FHC ,000 KLHL13 kelch-like 13 (Drosophila) FXC11103M 50,000 FHC ,000 KLHL14 kelch-like 14 (Drosophila) FXC ,000 FHC ,000 KLHL21 kelch-like 21 (Drosophila) FXC07649M 50,000 FHC ,000 KLHL25 kelch-like 25 (Drosophila) FXC ,000 FHC ,000 KLHL28 kelch-like 28 (Drosophila) FXC11370M 50,000 FHC ,000 KLHL3 kelch-like 3 (Drosophila) FXC ,000 FHC ,000 KLHL36 kelch-like 36 (Drosophila) FXC11063M 50,000 FHC ,000 KLHL4 Kelch-like protein 4 FXC ,000 FHC ,000 KLHL8 kelch-like 8 (Drosophila) FXC ,000 FHC ,000 KRBA1 KRAB-A domain containing 1 FXC ,000 FHC ,000 LDB1 LIM domain-binding protein 1 (Nuclear LIM interactor)(carboxyl-terminal LIM domain-binding protein FXC ,000 FHC ,000 2)(CLIM-2)(LIM domain-binding factor CLIM2)(hLdb1) LDB2 LIM domain binding 2 FXC ,000 FHC ,000 LDOC1 leucine zipper, down-regulated in cancer 1 FXC ,000 FHC ,000 LEF1 lymphoid enhancer-binding factor 1 FXC ,000 FHC ,000 LHX1 LIM homeobox 1 FXC ,000 FHC ,000 LHX2 LIM/homeobox protein Lhx2 (LIM homeobox protein 2)(Homeobox protein LH-2) FXC ,000 FHC ,000 LHX3 LIM homeobox 3 FXC23708M 50,000 FHC ,000 LHX4 LIM homeobox 4 FXC ,000 FHC ,000 LHX5 LIM homeobox 5 FXC ,000 FHC ,000 LHX8 LIM homeobox 8 FXC27665M 50,000 FHC ,000 LHX9 LIM homeobox 9, transcript variant 1 FXC20752M 50,000 FHC ,000 LIMA1 LIM domain and actin binding 1 FXC ,000 FHC ,000 LITAF lipopolysaccharide-induced TNF factor FXC28362M 50,000 FHC ,000 LMO1 LIM domain only 1 (rhombotin 1) FXC31671M 50,000 FHC ,000 LMO2 LIM domain only 2 (rhombotin-like 1) FXC ,000 FHC ,000 LMO3 LIM domain only 3 (rhombotin-like 2) FXC ,000 FHC ,000 LMO4 LIM domain transcription factor LMO4 FXC ,000 FHC ,000 LMX1A LIM homeobox transcription factor 1, alpha FXC ,000 FHC ,000 LMX1B LIM homeobox transcription factor 1-beta (LIM/homeobox protein LMX1B)(LIM/homeobox protein 1.2)(LMX-1.2) FXC ,000 FHC ,000 LYL1 lymphoblastic leukemia derived sequence 1 FXC ,000 FHC ,000 LZTR1 leucine-zipper-like transcription regulator 1 FXC ,000 FHC ,000 LZTS1 leucine zipper, putative tumor suppressor 1 FXC23208M 50,000 FHC ,000 MAFB v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) FXC ,000 FHC ,000 MAFF v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian), transcript variant 1 FXC27251M 50,000 FHC ,000 MAFG v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) FXC ,000 FHC ,000 MAFK v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) FXC ,000 FHC ,000 MAML3 mastermind-like 3 (Drosophila) FXC ,000 FHC ,000 MAMLD1 mastermind-like domain containing 1 FXC ,000 FHC ,000 MAX MYC associated factor X FXC ,000 FHC ,000

9 MAZ MYC-associated zinc finger protein (purine-binding transcription factor) FXC10828M 50,000 FHC ,000 MBD1 Methyl-CpG-binding domain protein 1 (Methyl-CpG-binding protein MBD1)(Protein containing methyl-cpg-binding domain FXC ,000 FHC ,000 1)(CXXC-type zinc finger protein 3) MECP2 methyl CpG binding protein 2 (Rett syndrome) FXC ,000 FHC ,000 MED12 mediator complex subunit 12 FXC ,000 FHC ,000 MED12 mediator complex subunit 12 FXC12080M 50,000 FHC ,000 MED14 mediator complex subunit 14 FXC27350M 50,000 FHC ,000 MED15 mediator complex subunit 15 FXC ,000 FHC ,000 MED16 mediator complex subunit 16 FXC ,000 FHC ,000 MED17 mediator complex subunit 17 FXC ,000 FHC ,000 MED21 mediator complex subunit 21 FXC ,000 FHC ,000 MED26 mediator complex subunit 26 FXC ,000 FHC ,000 MED27 Mediator of RNA polymerase II transcription subunit 27 (Mediator complex subunit 27)(Cofactor required for Sp1 transcriptional activation subunit 8)(CRSP complex subunit FXC ,000 FHC ,000 8)(Transcriptional coactivator CRSP34)(P37 MED6 mediator complex subunit 6 FXC ,000 FHC ,000 MED7 mediator complex subunit 7 FXC ,000 FHC ,000 MEF2A myocyte enhancer factor 2A FXC ,000 FHC ,000 MEF2B myocyte enhancer factor 2B FXC10992M 50,000 FHC ,000 MEF2C myocyte enhancer factor 2C FXC ,000 FHC ,000 MEF2D myocyte enhancer factor 2D FXC ,000 FHC ,000 MEIS1 Homeobox protein Meis1 FXC ,000 FHC ,000 MEIS2 Meis homeobox 2 FXC ,000 FHC ,000 MEIS3 Meis homeobox 3 FXC ,000 FHC ,000 MEIS3 Meis homeobox 3 FXC ,000 FHC ,000 MEOX1 Homeobox protein MOX-1 (Mesenchyme homeobox 1) FXC ,000 FHC ,000 MEOX2 mesenchyme homeobox 2 FXC ,000 FHC ,000 MESP1 mesoderm posterior 1 homolog (mouse) FXC25503M 50,000 FHC ,000 MESP2 mesoderm posterior 2 homolog (mouse) FXC11542M 50,000 FHC ,000 MID1 midline 1 (Opitz/BBB syndrome) FXC ,000 FHC ,000 MIER1 mesoderm induction early response 1 homolog (Xenopus FXC10824M 50,000 FHC ,000 MIER3 mesoderm induction early response 1, family member 3 FXC ,000 FHC ,000 MITF Microphthalmia-associated transcription factor FXC ,000 FHC ,000 MLL myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila), transcript variant 2 FXC28075M 50,000 FHC ,000 MLLT1 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 FXC ,000 FHC ,000 MLLT3 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 FXC ,000 FHC ,000 MLLT6 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 FXC ,000 FHC ,000 MLX Max-like protein X (Max-like bhlhzip protein)(bigmax protein)(protein Mlx)(Transcription factor-like protein 4) FXC ,000 FHC ,000 MLXIPL Williams-Beuren syndrome chromosomal region 14 protein (WS basic-helix-loop-helix leucine zipper protein)(wsbhlh)(mlx FXC ,000 FHC03526M 60,000 interactor)(mlx-interacting protein-like) MNAT1 menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis) FXC ,000 FHC ,000 MNT MAX binding protein FXC ,000 FHC ,000 MSC musculin (activated B-cell factor-1) FXC ,000 FHC ,000 MSX1 msh homeobox 1 FXC ,000 FHC ,000 MSX2 msh homeobox 2 FXC08787M 50,000 FHC ,000 MTA1 metastasis associated 1 FXC10817M 50,000 FHC ,000 MTA2 Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1)(MTA1-L1 protein)(p53 target protein in deacetylase FXC ,000 FHC ,000 MTF2 metal response element binding transcription factor 2 FXC20409M 50,000 FHC ,000 MXD1 MAX dimerization protein 1 FXC ,000 FHC ,000 MXD4 MAX dimerization protein 4 FXC ,000 FHC ,000 MXI1 MAX interactor 1 FXC ,000 FHC ,000 MYB Myb proto-oncogene protein (C-myb) FXC ,000 FHC ,000 MYBBP1A MYB binding protein (P160) 1a, transcript variant 2 FXC25835M 110,000 FHC25835M 120,000 MYBBP1A MYB binding protein (P160) 1a, transcript variant 1 FXC25836M 110,000 FHC25836M 120,000 MYBL1 v-myb myeloblastosis viral oncogene homolog (avian)-like 1 FXC31237M 50,000 FHC ,000 MYBL2 Myb-related protein B (B-Myb) FXC ,000 FHC ,000 MYC v-myc myelocytomatosis viral oncogene homolog (avian) FXC ,000 FHC ,000 MYC Myc proto-oncogene protein (c-myc)(transcription factor p64) FXC ,000 FHC ,000 MYC Myc proto-oncogene protein (c-myc)(transcription factor p64) FXC ,000 FHC ,000 MYCL1 L-myc-1 proto-oncogene protein FXC ,000 FHC ,000

10 MYCN v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) FXC ,000 FHC ,000 MYF5 myogenic factor 5 FXC ,000 FHC ,000 MYF6 Myogenic factor 6 (Myf-6) FXC ,000 FHC ,000 MYNN myoneurin FXC ,000 FHC ,000 MYOD1 myogenic differentiation 1 FXC ,000 FHC ,000 MYOG myogenin (myogenic factor 4) FXC ,000 FHC ,000 MYT1 myelin transcription factor 1 FXC ,000 FHC ,000 MYT1L myelin transcription factor 1-like FXC ,000 FHC ,000 NAB1 NGFI-A binding protein 1 (EGR1 binding protein 1) FXC ,000 FHC ,000 NAB2 NGFI-A binding protein 2 (EGR1 binding protein 2) FXC ,000 FHC ,000 NACC2 NACC family member 2, BEN and BTB (POZ) domain FXC08802M 50,000 FHC ,000 NANOG Homeobox protein NANOG FXC12077M 50,000 FHC ,000 NCOA2 nuclear receptor coactivator 2 FXC ,000 FHC ,000 NCOA3 nuclear receptor coactivator 3 FXC ,000 FHC ,000 NCOA4 nuclear receptor coactivator 4 FXC ,000 FHC ,000 NCOA6 nuclear receptor coactivator 6 FXC ,000 FHC ,000 NCOR1 nuclear receptor co-repressor 1 FXC ,000 FHC ,000 NCOR2 nuclear receptor co-repressor 2 FXC ,000 FHC ,000 NEUROD1 neurogenic differentiation 1 FXC ,000 FHC ,000 NEUROD2 neurogenic differentiation 2 FXC ,000 FHC ,000 NEUROD4 Neurogenic differentiation factor 4 (NeuroD4)(Protein atonal homolog 3)(Atoh3)(ATH-3) FXC ,000 FHC ,000 NEUROD6 neurogenic differentiation 6 FXC ,000 FHC ,000 NEUROG1 neurogenin 1 FXC ,000 FHC ,000 NEUROG2 neurogenin 2 FXC ,000 FHC ,000 NEUROG3 neurogenin 3 FXC ,000 FHC ,000 NFAT5 nuclear factor of activated T-cells 5, tonicity-responsive FXC ,000 FHC ,000 NFATC2 nuclear factor of activated T-cells, cytoplasmic, calcineurindependent 2 FXC11780M 50,000 FHC ,000 NFATC3 nuclear factor of activated T-cells, cytoplasmic, calcineurindependent 3 FXC09749M 50,000 FHC ,000 NFATC4 Nuclear factor of activated T-cells, cytoplasmic 4 (NF- ATc4)(NFATc4)(T-cell transcription factor NFAT3)(NF-AT3) FXC ,000 FHC ,000 NFE2 nuclear factor (erythroid-derived 2), 45kDa FXC ,000 FHC ,000 NFE2L1 nuclear factor (erythroid-derived 2)-like 1 FXC ,000 FHC ,000 NFE2L2 nuclear factor (erythroid-derived 2)-like 2 FXC ,000 FHC ,000 NFE2L3 nuclear factor (erythroid-derived 2)-like 3 FXC22882M 50,000 FHC ,000 NFIA nuclear factor I/A FXC ,000 FHC ,000 NFIB Nuclear factor 1 B-type (Nuclear factor 1/B)(NF1-B)(NFI- B)(NF-I/B)(CCAAT-box-binding transcription FXC ,000 FHC ,000 factor)(ctf)(tggca-binding protein) NFIC nuclear factor I/C (CCAAT-binding transcription factor) FXC08611M 50,000 FHC ,000 NFIL3 nuclear factor, interleukin 3 regulated FXC ,000 FHC ,000 NFIX nuclear factor I/X (CCAAT-binding transcription factor) FXC ,000 FHC ,000 NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B- cells 1 FXC ,000 FHC ,000 NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B- cells 1, transcript variant 1 FXC11986M 80,000 FHC11986M 90,000 NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B- cells 2 (p49/p100) FXC ,000 FHC ,000 NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B- cells inhibitor, alpha FXC ,000 FHC ,000 NFKBIB nuclear factor of kappa light polypeptide gene enhancer in B- cells inhibitor, beta FXC ,000 FHC ,000 NFKBIE nuclear factor of kappa light polypeptide gene enhancer in B- cells inhibitor, epsilon FXC29168M 50,000 FHC ,000 NFKBIL1 nuclear factor of kappa light polypeptide gene enhancer in B- cells inhibitor-like 1 isoform 3 FXC ,000 FHC ,000 NFX1 nuclear transcription factor, X-box binding 1 FXC ,000 FHC ,000 NFYA nuclear transcription factor Y, alpha FXC ,000 FHC ,000 NFYB nuclear transcription factor Y, beta FXC ,000 FHC ,000 NFYC nuclear transcription factor Y, gamma FXC ,000 FHC ,000 NHLH1 nescient helix loop helix 1 FXC ,000 FHC ,000 NHLH2 Helix-loop-helix protein 2 (HEN2)(Nescient helix loop helix 2)(NSCL-2) FXC ,000 FHC ,000 NKRF NFKB repressing factor FXC ,000 FHC ,000 NKX2-1 NK2 homeobox 1 FXC10939M 50,000 FHC ,000 NKX2-2 NK2 homeobox 2 FXC ,000 FHC ,000 NKX2-3 Homeobox protein Nkx-2.3 FXC11568M 50,000 FHC ,000 NKX2-5 NK2 transcription factor related, locus 5 (Drosophila) FXC ,000 FHC ,000

11 NKX3-1 NK3 homeobox 1 FXC ,000 FHC ,000 NKX3-2 NK3 homeobox 2 FXC ,000 FHC ,000 NKX6-2 NK6 homeobox 2 FXC24074M 50,000 FHC ,000 NKX6-3 Homeobox protein Nkx-6.3 FXC ,000 FHC ,000 NMI N-myc-interactor (Nmi)(N-myc and STAT interactor) FXC ,000 FHC ,000 NOBOX NOBOX oogenesis homeobox FXC ,000 FHC ,000 NPAS1 neuronal PAS domain protein 1 FXC26706M 50,000 FHC ,000 NPAS3 neuronal PAS domain protein 3 FXC ,000 FHC ,000 NR0B1 nuclear receptor subfamily 0, group B, member 1 FXC ,000 FHC ,000 NR0B2 nuclear receptor subfamily 0, group B, member 2 FXC20160M 50,000 FHC ,000 NR1D1 nuclear receptor subfamily 1, group D, member 1 FXC ,000 FHC ,000 NR1D2 nuclear receptor subfamily 1, group D, member 2 FXC ,000 FHC ,000 NR1H2 nuclear receptor subfamily 1, group H, member 2 FXC ,000 FHC ,000 NR1H3 nuclear receptor subfamily 1, group H, member 3 FXC ,000 FHC ,000 NR1H4 nuclear receptor subfamily 1, group H, member 4 FXC ,000 FHC ,000 NR1I2 nuclear receptor subfamily 1, group I, member 2, transcript variant 1 FXC31716M 70,000 FHC31716M 80,000 NR1I2 Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PXR)(Pregnane X receptor)(orphan nuclear FXC ,000 FHC ,000 receptor PAR1)(Steroid and xenobiotic receptor)(sxr) NR1I3 nuclear receptor subfamily 1, group I, member 3 FXC20672M 60,000 FHC20672M 70,000 NR2C1 nuclear receptor subfamily 2, group C, member 1 FXC24833M 50,000 FHC ,000 NR2C2 nuclear receptor subfamily 2, group C, member 2 FXC ,000 FHC ,000 NR2E1 nuclear receptor subfamily 2, group E, member 1 FXC ,000 FHC ,000 NR2E3 nuclear receptor subfamily 2, group E, member 3 FXC11121M 50,000 FHC ,000 NR2F1 nuclear receptor subfamily 2, group F, member 1 FXC ,000 FHC ,000 NR2F2 nuclear receptor subfamily 2, group F, member 2 FXC10946M 50,000 FHC ,000 NR2F6 nuclear receptor subfamily 2, group F, member 6 FXC ,000 FHC ,000 NR3C1 nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) FXC ,000 FHC ,000 NR3C2 nuclear receptor subfamily 3, group C, member 2 FXC22071M 130,000 FHC22071M 140,000 NR4A1 nuclear receptor subfamily 4, group A, member 1 FXC ,000 FHC ,000 NR4A1 nuclear receptor subfamily 4, group A, member 1 FXC08830M 50,000 FHC ,000 NR4A2 nuclear receptor subfamily 4, group A, member 2 FXC21198M 50,000 FHC ,000 NR4A3 nuclear receptor subfamily 4, group A, member 3 FXC ,000 FHC ,000 NR5A1 nuclear receptor subfamily 5, group A, member 1 FXC ,000 FHC ,000 NR5A2 nuclear receptor subfamily 5, group A, member 2 FXC11953M 50,000 FHC ,000 NRF1 Nuclear respiratory factor 1 FXC ,000 FHC ,000 NRIP1 nuclear receptor interacting protein 1 FXC ,000 FHC ,000 NRL neural retina leucine zipper FXC ,000 FHC ,000 OLIG1 oligodendrocyte transcription factor 1 FXC ,000 FHC ,000 OLIG3 oligodendrocyte transcription factor 3 FXC ,000 FHC ,000 ONECUT1 one cut homeobox 1 FXC ,000 FHC ,000 OPTN optineurin FXC ,000 FHC ,000 OSR1 odd-skipped related 1 (Drosophila) FXC10938M 50,000 FHC ,000 OTP Homeobox protein orthopedia FXC ,000 FHC ,000 OTUD7B OTU domain containing 7B FXC29567M 50,000 FHC ,000 OTX1 Homeobox protein OTX1 (Orthodenticle homolog 1) FXC ,000 FHC ,000 OTX2 orthodenticle homeobox 2 FXC ,000 FHC ,000 OVOL1 ovo-like 1(Drosophila) FXC ,000 FHC ,000 OVOL2 ovo-like 2 (Drosophila) FXC ,000 FHC ,000 PATZ1 POZ (BTB) and AT hook containing zinc finger 1 FXC ,000 FHC ,000 PAWR PRKC, apoptosis, WT1, regulator FXC28161M 50,000 FHC ,000 PAX2 paired box 2 FXC ,000 FHC ,000 PAX3 paired box 3, transcript variant PA FXC21332M 50,000 FHC ,000 PAX4 paired box 4 FXC ,000 FHC ,000 PAX5 paired box 5 FXC ,000 FHC ,000 PAX6 Paired box protein Pax-6 (Oculorhombin)(Aniridia type II FXC ,000 FHC ,000 PAX7 paired box 7, transcript variant 2 FXC20120M 50,000 FHC ,000 PAX8 Paired box protein Pax-8 FXC ,000 FHC ,000 PAX9 paired box 9 FXC ,000 FHC ,000 PBX1 pre-b-cell leukemia homeobox 1 FXC ,000 FHC ,000 PBX2 Pre-B-cell leukemia transcription factor 2 FXC ,000 FHC ,000 PBX3 pre-b-cell leukemia homeobox 3 FXC ,000 FHC ,000 PCGF2 polycomb group ring finger 2 FXC ,000 FHC ,000 PCGF3 polycomb group ring finger 3 FXC21835M 50,000 FHC ,000 PDX1 pancreatic and duodenal homeobox 1 FXC ,000 FHC ,000 PER1 period homolog 1 (Drosophila) FXC ,000 FHC ,000 PER2 period homolog 2 (Drosophila) FXC ,000 FHC ,000 PER3 period homolog 3 (Drosophila) FXC ,000 FHC ,000

研究成果報告書(基金分)

研究成果報告書(基金分) 5 30 90 QSTAR-Elite LC-MS/MS(AB Sciex) Liquid tissue MS protein prep (AMR ) ( Zwittergent ) (1) 2002 1 2010 12 123 50 67.6 ± 9.5 (35-85) 26 24 603 (94-2969 ) 10% 3 (2) 9um 2um - (HE) 0.002% Zwittergent

More information

計算機生命科学の基礎II_

計算機生命科学の基礎II_ Ⅱ 1.4 atsushi_doi@cell-innovator.com 812-8582 3-1-1 8 806 http://www.cell-innovator.com BioGPS Connectivity Map The Cancer Genome Atlas (TCGA); cbioportal GO DAVID, GSEA WCGNA BioGPS http://biogps.org/

More information

総括研究成果報告書

総括研究成果報告書 BILD 1 diethylstilbestrol (DES) estrogen DNA embryonic stem (ES) ES ES A3-1 ES ES Genetic Microsystems DNA 2 3 DNA DNA DNA BILD ES ES ES RNA RNA cdna DNA DNA estrogen MCF-7 RNA DNA ES mrna Differential

More information

ミニレビュー

ミニレビュー Molecular mechanisms of the suppression of inflammation by thermal stress Ryosuke Takii Department of Biochemistry and Molecular Biology, Yamaguchi University Graduate School of Medicine, Ube 755-8505,

More information

サイトメトリー12-1.indd

サイトメトリー12-1.indd Cell Growth Inhibition and Apoptosis in Cancer Cells Kazuki Omoteyama, Shoichi Inoue and Alaa-eldin Salah-eldin Department of Environmental Medicine and Informatics, Graduate School of Environmental Earth

More information

研究成果報告書

研究成果報告書 21 5 28 2007 2008 CARElk CARPXR CAR CAR EST cdna CAR CAR 10FCS 96 SW480 HepG2 anti-lamin A/C anti-phospho-histone H3 anti-cyclin D1 G1 anti-cyclin A S CAR lamin A/C CAR Fig. 1 Lamin A/C /G1 lamin A/C G1

More information

_統合化推進プログラム_金久チーム_サイトビジット資料

_統合化推進プログラム_金久チーム_サイトビジット資料 ライフサイエンスデータベース統合推進事業統合化推進プログラム ゲノム 疾患 医薬品のネットワークデータベース実施状況 京都大学化学研究所 金久 實 2018 年 8 月 22 日サイトビジット資料 KEGG NETWORK とは NAR DB Issue 2017 KEGG: new perspectives on genomes, pathways, diseases and drugs From

More information

第79回_プログラム.indd

第79回_プログラム.indd Regulation of ghrelin signaling by a leptin-induced gene, negative regulatory element-binding protein, in the hypothalamic neurons. Phase I clinical trial using peptide vaccine for human vascular endothelial

More information

チ ィー ィィ090601ィィィー, ツ ィケ, ィコ 01ィィ ィェ02ィィィ 05ィケィェ06ィヲ 05ィコ ィィィィ 070

チ ィー ィィ090601ィィィー, ツ ィケ, ィコ 01ィィ ィェ02ィィィ 05ィケィェ06ィヲ 05ィコ ィィィィ 070 130108 07 チ 010403 0209 0502 0404 0102ィェ02ィーィィィコィ 08ィ 0409ィィィーィィ07 090209ィーィィィ ィョ050708ィェ06ィヲ 09ィィ09ィー02ィャ04 000005ィィ ィェ0202 00.08. 0802010208ィ 05ィケィェ0602 000609ィョ01ィ 0809ィー0902ィェィェ0602 ィ 06010302ィーィェ0602

More information

日本組織適合性学会誌第23巻2号

日本組織適合性学会誌第23巻2号 Major Histocompatibility Complex 2016; 23 (2): 115 122 HLA 1 1) 1) HLA MHC 1900 HLA HLA キーワード : HLA HLA HLA HLA 2 HLA HLA HLA 3 1 1 HLA HLA 図 1 2016 6 30 2016 8 2 105 0013 1 10 14 3 5 TEL: 03 5776 0048

More information

Microsoft PowerPoint

Microsoft PowerPoint ニコチン受容体を介するステロイド産生幹細胞の分化制御 矢澤隆志 ( 旭川医科大学生化学講座細胞制御科学分野 ) コレステロール StAR コレステロール CYP11A1 プレグネノロン CYP17A1 17α-OH pregnenolone CYP17A1 DHEA 生殖腺 3β-HSD CYP19A1 プロゲステロン 17α-OH progesterone Androstenedione Estrone

More information

日本糖尿病学会誌第58巻第2号

日本糖尿病学会誌第58巻第2号 β γ Δ Δ β β β l l l l μ l l μ l l l l α l l l ω l Δ l l Δ Δ l l l l l l l l l l l l l l α α α α l l l l l l l l l l l μ l l μ l μ l l μ l l μ l l l μ l l l l l l l μ l β l l μ l l l l α l l μ l l

More information

園田学園論文集 45号(よこ)☆/10.出口

園田学園論文集 45号(よこ)☆/10.出口 45 2011. 1 Summary : Changes in gene expression in adipocytes are considered to be involved in adipocyte growth and differentiation. Hyperlipidemia with atherosclerosis shows several evidences of importance

More information

新技術説明会 様式例

新技術説明会 様式例 1 皮膚細胞が乳酸菌を取り込むと 多能性細胞になる 熊本大学大学院生命科学研究部 准教授太田訓正 2 幹細胞とは 人間では一つの受精卵から 200 種類以上 約六〇兆個の細胞が作られる 多種多様な細胞にも もとをたどると親の細胞に行き当たり それを幹細胞 (stem cell) と呼び 体性幹細胞 ES 細胞 ips 細胞がある 3 従来の幹細胞の特徴とその問題点 細胞体性幹細胞 ES 細胞 ips

More information

好中球とPTX3

好中球とPTX3 Neutrophils and pentraxin 3 Makoto Naito, Alexander S. Savchenko and Akira Inoue Pentraxin 3 (PTX3) is the first identified long pentraxin, and is rapidly produced and released by several cell types in

More information

m «É w «Ÿ ÉÉ É É ÉÉ É É

m «É w «Ÿ ÉÉ É É ÉÉ É É É ÉÉÉÉ ÉÉ Zacc m «É w «Ÿ ÉÉ É É ÉÉ É É É É É É É É É ÉÉ É Uninephrectomy induces Progressive Glomerulosclerosis and Apoptosis in Anti Thy Glomerulonephritis VEGF Gene Expression is Correlated with Glomerular

More information

RUO13_2.indd

RUO13_2.indd MBL RUO TOPICS 研究用 13 vol. Dec. 2013 ーペ ペン ン特 ンャ ャキ ー集 キ ン L ジ B ー M 号 ペ 集 特全 抗体い グ タ め買 まと p p.2 セチ 試薬 ) ア 脱 関連 yclex (C ン ト ナル ス ヒ ロー ル 抗 ク 体 ーナ ) ノ 抗クロ 究所 モ ノ 研 体 4 p.1 6 p.1 ム タイ ル リア CR用 ス P ミック s

More information

PowerPoint Presentation

PowerPoint Presentation DNA 87 ( ) Nucleic Acids ResearchDB RNA 29 94 58 29 18 43 153 : 511 Bio DB Catalog (DBCAT) http://www.infobiogen.fr/services/dbcat/ 2 GenBank MB SRS) DAS) 3 4 5 A A A 6 OGSA-DAI 7 9 DB Medical Encyclopedia

More information

小児感染免疫第25巻第2号

小児感染免疫第25巻第2号 2013 Vol. 25No. 2175 44 1972 28 1 Kikuchi s diseasekikuchifujmoto diseasehistiocytic necrotizing lymphadenitis Histiocytic necrotizing lymphadenitis, Kikuchi s disease, KikuchiFujimoto disease, subacute

More information

Sulfonylurea Receptors Pancreatic Type: SUR1 Cardiac Type: SUR2A Smooth Muscle Type: SUR2B Kir Channels uka-rp-1/kir6.1 BIR/Kir6.2 1) Ho K, et al : Cloning and expression of an inwardly rectifying ATP-regulated

More information

ÿþ

ÿþ TNF ファミリー 腫瘍壊死因子 ( Tumor Necrosis Factor: TNF) は 固形がんに対して出血性の壊死を誘導する因子として発見されたサイトカインです TNF ファミリーには TNF-α リンフォトキシンα Fas リガンドや TRAIL などのアポトーシス誘導に関与するサイトカインのほか RANK リガンド OX40 リガンド APRIL など 20 種類近くに因子が同定されています

More information

研究成果報告書(基金分)

研究成果報告書(基金分) The most remarkable characteristic of the mammalian neocortex is its layered structure. Because all, but only the mammalian species, have this layered structure in the telencephalon, it has been accepted

More information

Title 骨量規定転写因子シュニュリ3の新規標的遺伝子同定と機能解析 Author(s) 石堂, 康弘 Citation Issue Date 2014-06-27 URL http://hdl.handle.net/10232/24125 http://ir.kagoshima-u.ac.jp adult (Schnurri, Shn)3/Hivep3 Runx2 Shn/Hivep Shn3

More information

Major Histocompatibility Complex 2018; 25 (2): 抄録集 2 HLA A 3 128

Major Histocompatibility Complex 2018; 25 (2): 抄録集 2 HLA A 3 128 Major Histocompatibility Complex 2018; 25 (: 128 138 抄録集 2018 4 14 A 3 128 MHC 2018; 25 ( HLA 2013 10.5 10 8 12 10 8 2016 CD34 + HLA NC 10 8 CD34 + CD34 + 10 6 NC10.5 2013.Apr 2014.Mar NC11 2014.Apr 2016.Jun

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション 今回の第 91 回日本内分泌学会での発表は 査読高得点演題 として 学会場の大型スクリーンで紹介されました Kallmann syndrome についての概説 1. Kallmann syndrome は嗅覚性器症候群 (Olfacto-genital syndrome) とも称される 先天性の視床下部性性腺機能低下症に嗅覚欠損を伴う症候群 である 2. 本来性腺そのものには異常はなく 視床下部からの

More information

1. Tanaka Y, Hamano S, Gotoh K, Murata Y, Kunisaki Y, Nishikimi A, Takii R, Kawaguchi M, Inayoshi A, Masuko S, Himeno K, Sasazuki T, Fukui Y. T helper

1. Tanaka Y, Hamano S, Gotoh K, Murata Y, Kunisaki Y, Nishikimi A, Takii R, Kawaguchi M, Inayoshi A, Masuko S, Himeno K, Sasazuki T, Fukui Y. T helper 1. Tanaka Y, Hamano S, Gotoh K, Murata Y, Kunisaki Y, Nishikimi A, Takii R, Kawaguchi M, Inayoshi A, Masuko S, Himeno K, Sasazuki T, Fukui Y. T helper type 2 differentiation and intracellular trafficking

More information

スライド 1

スライド 1 2 (2007 ) 9:25 10:55 akio@sfc.keio.ac.jp knakahig@sfc.keio.ac.jp ktsuge@ttck.keio.ac.jp TTCK SFC 1 2 DNA RNA mrna mrna RNA 3 2007 ( ) Part 1 DNA Part 2 PCR DNA ( ) Part 3 RNA Part 4 Chapter 8 (p.243-260)

More information

熊本大学学術リポジトリ Kumamoto University Repositor Title 炎症性腸疾患に対する HSF1 及び HSP70 の保護的役割 Author(s) 田中, 健一郎 Citation Issue date Type URL Thesis or Di

熊本大学学術リポジトリ Kumamoto University Repositor Title 炎症性腸疾患に対する HSF1 及び HSP70 の保護的役割 Author(s) 田中, 健一郎 Citation Issue date Type URL Thesis or Di 熊本大学学術リポジトリ Kumamoto University Repositor Title 炎症性腸疾患に対する HSF1 及び HSP70 の保護的役割 Author(s) 田中, 健一郎 Citation Issue date 2008-03-25 Type URL Thesis or Dissertation http://hdl.handle.net/2298/9448 Right 1

More information

MAP MAP MAP MAPKKK /MAP MAPKK /MAP MAPK MAPK MAP Microtubule associated protein 2 MAP Dundee Sturgill MAP MAP ERK1 ERK2 MAP Nerve Growth Factor NGF MA

MAP MAP MAP MAPKKK /MAP MAPKK /MAP MAPK MAPK MAP Microtubule associated protein 2 MAP Dundee Sturgill MAP MAP ERK1 ERK2 MAP Nerve Growth Factor NGF MA 四 細胞生物学 八月 東京大学理学部生物化学科卒業 すけ 昭和二八年 東京大学大学院理学系研究科博士課程修了 介 昭和五一年 理学博士 えい 日本学術振興会奨励研究員 栄 東京大学理学部助手 だ 六月 京都大学ウイルス研究所教授 田 五月 京都大学大学院理学研究科教授 にし 五年 京都大学大学院生命科学研究科教授 現在に至る 西 平成 九年 京都大学大学院生命科学研究科長 平成二一年まで 受賞者 専攻学科目

More information

ClinCal_WADA

ClinCal_WADA 1 Roles of the BMP family in pattern formation of the vertebrate limb Naoyuki Wada 1, Tsutomu Nohno 1, Sumihare Noji 2 1 Department of Molecular Biology, Kawasaki Medical School, 577 Matsushima, Kurashiki,

More information

PowerPoint Presentation

PowerPoint Presentation 1 Cutaneous T- cell lymphoma) 2) 2001 WHO - - - PS LDH soluble IL- B 38.5 C 10 International Prognostic Index IPI International prognostic factor and index Prognostic factor >60 LDH > PS 2-4 Stage III

More information

2

2 2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary

More information

A b a B AaBb Ab ab 1 1 AB ab A-b a-b 2.Meiosis recombination Meiosis mitosis crossover recombination bivalent DNA 2

A b a B AaBb Ab ab 1 1 AB ab A-b a-b 2.Meiosis recombination Meiosis mitosis crossover recombination bivalent DNA 2 遺 伝 と 遺 伝 子 2007 年 度 参 考 問 題 リストの 解 答 例 xxax2002@yahoo.co.jp 2007 50 50 1. Mendel s second law of inheritance 2006 2006 A B A B Mendel s second law of inheritance principle of independent segregation P

More information

Vol.41 No.2◆改◆/◆0 目次[三]

Vol.41 No.2◆改◆/◆0 目次[三] ! Cucurbita maxima Myrciaria dubia Department of Science and Technology on Food Safety, Kinki University, 930 Nishimitani, Kinokawa, Wakayama 649 6493 RI Center, Wakayama Medical University School of Medicine,

More information

yakugaku-kot.ppt

yakugaku-kot.ppt 2009 Masaaki Kotera kot@kuicr.kyoto-u.ac.jp 2 I II / A () B1 () B2 B12 C () D A D () () () () DNA 5- http://www.genome.jp/kegg/pathway.html KEGG PATHWAY Database Xenobiotics biodegradation http://www.genome.jp/kegg/pathway.html

More information

untitled

untitled 21 1 26 1 US6759035University of Southern California 1. A method for decreasing graft rejection of a solid organ by a recipient comprising: a) isolating peripheral blood mononuclear cells (PBMC) from a

More information

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 ポスターについて 1. ポスター 貼 付 用 の 展 示 ボードは 縦 180 横 90cm の 大 きさです 2. 演 題 名 発 表 者 名 所 属 を 明 記 したもの(20 70cm) をご 用 意 ください 実 際 使 用 できるスペースは 155

More information

受賞講演要旨2012cs3

受賞講演要旨2012cs3 アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート α β α α α α α

More information

Biotinylated Kinases BTNABL(ABL1) Tyrosineprotein kinase ABL1 Biotinylated N 2 Nterminal DYKDDDDK カルタヘナ 80 BTNACTR2B(ACVR2B) Activin r

Biotinylated Kinases BTNABL(ABL1) Tyrosineprotein kinase ABL1 Biotinylated N 2 Nterminal DYKDDDDK カルタヘナ 80 BTNACTR2B(ACVR2B) Activin r 2. ビオチン化キナーゼタンパク質 Biotinylated Kinases 表面プラズモン共鳴 (SPR) やバイオレイヤー干渉法 (BLI) といった物質間の相互作用を評価する系 ( 解析機器 ) でご利用いただけるビオチン化キナーゼタンパク質を販売しております これらの解析機器で低分子化合物の創薬研究 開発を行なう際 リガンドとする標的分子蛋白質を活性 構造を保持したままセンサー表面に固定化

More information

一般演題(ポスター)

一般演題(ポスター) 6 5 13 : 00 14 : 00 A μ 13 : 00 14 : 00 A β β β 13 : 00 14 : 00 A 13 : 00 14 : 00 A 13 : 00 14 : 00 A β 13 : 00 14 : 00 A β 13 : 00 14 : 00 A 13 : 00 14 : 00 A β 13 : 00 14 : 00 A 13 : 00 14 : 00 A

More information

Microsoft PowerPoint - talk pptx

Microsoft PowerPoint - talk pptx 生物学者のための マイクロアレイと次世代シークエンス データ解析の実際 2011 年 11 月 15 日帝京大学 東京医科歯科大学大学院疾患生命科学研究部ゲノム構造制御田中裕二郎 chromatinstructure.wordpress.com なぜ次世代シークエンス (NGS) か 1. ヒストンメチル基転移酵素 ASH1 2. ストレス応答の転写制御因子ネットワーク マイクロアレイとNGSのデータ解析

More information

Accumulation of CD8 + lymphocytes and Mƒ³ in glomeruli occurs in WRY rats after anti-gbm antibody administration. However, a role of the antibody in the leukocyte accumulation is unclear. An involvement

More information

13-武田報告.indd

13-武田報告.indd 東北大学大学院医学系研究科医学生物化学講座分子生物学分野 武田和久 Microphthalmia-associated transcription factor (MITF) consists of many isoforms that differ at their N-termini but share a basic helix-loop-helix and leucine-zipper (bhlh-lz)

More information

能書単頁9[1].5(2)

能書単頁9[1].5(2) ips CytoTune -ips ver.1.0 1 I CytoTune ips 3 II 3 3 4 5 III CytoTune ips ips 6 6 6 6 7 1) 2) ips 8 ips 8 SeV 9 SeV 10 IV Q&A 11 V 12 12 VI...13 13...13 2 I CytoTune ips CytoTune ips 4 OCT3/4SOX2 KLF4c

More information

第85 回日本感染症学会総会学術集会後抄録(III)

第85 回日本感染症学会総会学術集会後抄録(III) β β α α α µ µ µ µ α α α α γ αβ α γ α α γ α γ µ µ β β β β β β β β β µ β α µ µ µ β β µ µ µ µ µ µ γ γ γ γ γ γ µ α β γ β β µ µ µ µ µ β β µ β β µ α β β µ µµ β µ µ µ µ µ µ λ µ µ β µ µ µ µ µ µ µ µ

More information

総説 花房崇明先生.indd

総説 花房崇明先生.indd Jpn. J. Clin. Immunol., 37 (3)133~138 (2014)C 2014 The Japan Society for Clinical Immunology 133 総 説 中枢性及び末梢性免疫寛容における Aire の働き 花房崇明 Function of Aire in central and peripheral immune tolerance Takaaki Hanafusa

More information

B M B B B B B B C C C C CO 2Na N N H N N H N N Cl HN N Cl N N H N N N c C NH 2.HCl HO HO OH Me Me Me CO 2H N N NH 2 N Me Me C C C C C C C M M M M Movie BM BM BM 80M 80M Golgi ER Adam17 Fringe

More information

日本消化器外科学会雑誌第29巻第9号

日本消化器外科学会雑誌第29巻第9号 Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe

More information

クロマチン免疫沈降法 クロマチン免疫沈降 ChIP 法は 細胞のクロマチン中のタンパク質 DNA相互作用を調べる 強力かつ汎用性の高い手法で す 1,2 この手法は 特定のゲノム領域と関係している複数のタンパク質の同定や また逆に ある特定のタンパク質に関係 している多くのゲノム領域の同定に使用され

クロマチン免疫沈降法 クロマチン免疫沈降 ChIP 法は 細胞のクロマチン中のタンパク質 DNA相互作用を調べる 強力かつ汎用性の高い手法で す 1,2 この手法は 特定のゲノム領域と関係している複数のタンパク質の同定や また逆に ある特定のタンパク質に関係 している多くのゲノム領域の同定に使用され ChIP SimpleChIP Plus Enzymatic Chromatin IP Kit ChIP 2 3 New SimpleChIP Plus Enzymatic Chromatin IP Kit 4 CSTChIP 5 HCT116p53 ChIP 6 7 8 ChIP クロマチン免疫沈降法 クロマチン免疫沈降 ChIP 法は 細胞のクロマチン中のタンパク質 DNA相互作用を調べる 強力かつ汎用性の高い手法で

More information

MHC 2013; 20 (1) 11 参加費 1 2, , ,000 会議等 :50 14: :30 13: :00 会場地図 参天製薬株式会社本社案内図 TEL 新大阪駅より

MHC 2013; 20 (1) 11 参加費 1 2, , ,000 会議等 :50 14: :30 13: :00 会場地図 参天製薬株式会社本社案内図 TEL 新大阪駅より Major Histocompatibility Complex 2013; 20 (1): 63 89 抄録集 11 2013 2 2 3 9 19 TEL: 06 6321 7000 630 0293 1248 1 TEL: 0743 77 0880 E-mail: tubaki@nara.med.kindai.ac.jp 63 MHC 2013; 20 (1) 11 参加費 1 2,000 2

More information

薬 理 学 教 室

薬 理 学 教 室 業績目録 ( 平成 22 年 ) (B-a) 英文総説 1) Fan C, Katsuyama M, Wei H, Xia Q, Liu W, Yabe-Nishimura C. Molecular Mechanisms Underlying PGF2alpha-induced Hypertrophy of Vascular Smooth Muscle Cells. Yakugaku Zasshi

More information

Untitled

Untitled 上原記念生命科学財団研究報告集, 23(2009) 71. 間葉系細胞へ分化する能力を有するグリオーマ細胞の characterization と組織内局在 岩下寿秀 Key words: グリオーマ, 間葉系細胞,side population * 愛知医科大学医学部病理学講座 緒言腫瘍組織はヘテロな細胞集団であり,at random に増殖していると考えられてきたが, 最近の研究結果から腫瘍組織にも正常の組織と同様のヒエラルキーが存在する可能性が示唆されている.

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション 自己紹介 Self-introduction 岡山大学理学部線虫 C. elegans の骨格筋の発生 京都大学大学院医学研究科心筋肥大の転写機構 ES/iPS 細胞の心筋分化 国立循環器病研究センター動脈硬化の発生機序 ( 平滑筋 ) ミネソタ大学幹細胞研究所骨格筋幹細胞の増殖 分化 信州大学農学部 / バイオメディカル研究所 分子細胞機能学研究室 (C101) TEL : 0265-77-1426(

More information

表1.eps

表1.eps Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol

More information

14-2JAMTTCNL0913F

14-2JAMTTCNL0913F JAMTTC News Letter No.14-2 Sept. 2010 http://jamttc.umin.jp Japanese Association for Molecular Target Therapy of Cancer information September, 2010 1 News 2 Japanese Association for Molecular Target Therapy

More information

第86回日本感染症学会総会学術集会後抄録(II)

第86回日本感染症学会総会学術集会後抄録(II) χ μ μ μ μ β β μ μ μ μ β μ μ μ β β β α β β β λ Ι β μ μ β Δ Δ Δ Δ Δ μ μ α φ φ φ α γ φ φ γ φ φ γ γδ φ γδ γ φ φ φ φ φ φ φ φ φ φ φ φ φ α γ γ γ α α α α α γ γ γ γ γ γ γ α γ α γ γ μ μ κ κ α α α β α

More information

23590687 研究成果報告書(基金分)

23590687 研究成果報告書(基金分) , 5(41), p1-8, 2012. doi: 10.1186/1756-8722-5-41. 4. Takahashi S, Current findings for recurring mutations in acute myeloid leukemia, Journal of Hematology & Oncology,, 4(36), p1-11 ( Highly accessed article),

More information

171718 Proceedings of the Society A novel dicentric ring chromosome in Arabidopsis thaliana The CE1 elements enhance the adjacent gene expressions and bind transcription factors and chromatin recognition

More information

jcvp試験問題HP.indd

jcvp試験問題HP.indd 22 18 JCVP 1 G a e 1 G 1. A. B. C. D. P450 E. SOD c G 2. A. B. C. mrna D. E. G 3. G 4. A. B. ATP C. D. E. a A. B. C. 25 nm D. 10 nm E. 4 6 nm c d G 5. G 6. G 7. A. B. SOD C. D. E α E. d a. b. c. d. e.

More information

Anti-dimethyl Histone H3 (Lys9)

Anti-dimethyl Histone H3 (Lys9) MAB Institute, Inc. 82 Inaokacho, Yokosuka-shi, Kanagawa 238-8580, Japan TEL, FAX: +81 46-822-9328 Anti- Histone H3 (Lys36), mouse monoclonal antibody Catalog No. MABI0332-20, MABI0332-100 Lot No. 11001

More information

Microsoft PowerPoint - 04 池袋 一典 教授

Microsoft PowerPoint - 04 池袋 一典 教授 1 アプタマーの ヒトゲノム情報からの探索 及びコンピューター内進化 東京農工大学 大学院工学研究院 生命機能科学部門 教授 池袋一典 研究の背景 3 叉路型アプタマー 高い結合能を示すアプタマーの例 Target Library K d (nm) HIV-1 integrase RNA 10 FIV reverse transcriptase RNA 4.2 HIV-1 reverse transcriptase

More information

PCR Rotor-Gene Q PCR DN QIGEN PCR Rotor-Gene Q QIGEN Rotor-Gene Q Rotor-Gene Q PCR High Resolution Melt SNP QIGEN Rotor-Gene Q QIGEN PCR HRM High Reso

PCR Rotor-Gene Q PCR DN QIGEN PCR Rotor-Gene Q QIGEN Rotor-Gene Q Rotor-Gene Q PCR High Resolution Melt SNP QIGEN Rotor-Gene Q QIGEN PCR HRM High Reso Rotor-Gene Q PCR Sample to Insight PCR Rotor-Gene Q PCR DN QIGEN PCR Rotor-Gene Q QIGEN Rotor-Gene Q Rotor-Gene Q PCR High Resolution Melt SNP QIGEN Rotor-Gene Q QIGEN PCR HRM High Resolution Melt DN 8

More information

H24_大和証券_研究業績_p indd

H24_大和証券_研究業績_p indd インフルエンザウィルス感染症におけるエピジェネティック制御 慶應義塾大学医学部呼吸器内科 助教石井誠 ( 共同研究者 ) 慶應義塾大学医学部呼吸器内科助教溝口孝輔 はじめにインフルエンザウィルス感染症は 2009 年に新型インフルエンザウィルス (H1N1) が流行するなど現在でも社会的な脅威であり 重症化した場合の致命率は高く その病態のさらなる解明と適切な治療法の確立が急務である 遺伝子発現のエピジェネティクス

More information

免疫Ⅱ

免疫Ⅱ 100 100 100 1990 127 DNA DNA DNA DNA hybridization DNA RNA DNA DNA 128 12 µδγαε 129 300 1,200 500 50012 4 24,000 1,20024,000 2.910 7 10 8 rejection major histocompatibility complex MHC MHC MHC 130 MHC

More information

1. Ishida-Yamamoto A, Dera i son C, Bonnart C, B i toun E, Robinson R, O'Brien TJ,Wakamatsu K, Ohtsubo S, Takahashi H, Hashimoto Y, Dopping-Hepenstal PJ, McGrath JA, lizuka H, Richard G, Hovnanian A. LEKTI

More information

Microsoft PowerPoint - ⑦大上講師説明資料.ppt

Microsoft PowerPoint - ⑦大上講師説明資料.ppt 広島大学 新技術説明会 8/20 大阪 胃癌診断のための 高感受性血清腫瘍マーカー 広島大学大学院医歯薬学総合研究科分子病理 講師 大上 直秀 教授 安井 弥 研究背景 胃癌は近年減少してきているとはいえ 尚 最も頻度の高い癌の一つであり この克服は現代社会の最大の課題である 分子病理学研究室では 胃癌の発生 進展のメカニズムを解析し 胃癌の病態解明を行っている さらに そこから得られた知見をもとに

More information

9:30 11 : : : : : : : : : 50

9:30 11 : : : : : : : : : 50 9:30 11 : 00 12 : 00 12 : 15 13 : 50 14 : 30 15 : 00 15 : 10 16 : 30 16 : 50 発表者各自でご用意ください 医学会で用意します 20cm 70cm 演題番号 演題 所属 氏名 20cm 85cm ポスター掲示範囲 155cm 160cm 1 Skeletal muscle pathology of patients with

More information

15K00827 研究成果報告書

15K00827 研究成果報告書 (TG) TG sterol regulatory element- binding protein (SREBP)-1c (Diabetes 53:560-569, 2004) SREBP-1c (1) SREBP-1c SREBP-1c liver X receptor (LXR)LXR O-Glc NAc (O-linked -N-acetyl glucosamine) (J Biol Chem

More information

Immunological parameters such as lymphocyte subsets, blastogenesis, natural killer (NK) activity of peripheral blood lymphocytes, and serum interferon

Immunological parameters such as lymphocyte subsets, blastogenesis, natural killer (NK) activity of peripheral blood lymphocytes, and serum interferon Immunological parameters such as lymphocyte subsets, blastogenesis, natural killer (NK) activity of peripheral blood lymphocytes, and serum interferon activity were investigated on 40 oral cancer patients

More information

Untitled

Untitled 上原記念生命科学財団研究報告集, 24(2010) 145. 難治性白血病原因遺伝子 Evi-1 を起点とした omics 解析 合山進 Key words:evi-1, 造血幹細胞, 白血病, エピジェネティクス * 東京大学医学部附属病院輸血部 緒言 Evi-1 は骨髄性白血病や骨髄異形成症候群で高頻度に活性化されている転写因子であり,Evi-1 関連白血病は治療抵抗性で予後不良であるため, 白血病難治性の鍵となる分子として注目されている

More information

untitled

untitled T DAC8 2011 1 27 (DAC) DAC 11 DAC8 DAC8 T Leukemia. 2008, 22, 1026 1134. Clin. Cancer. Res. 2009, 15, 91 99. DAC8 1)DAC8 2) T T T-ALL 10 1 T-ALL 30~40% T CTCL 10 1 CTCL T ATLL 1 TLV-1 120 2,000 TLV-1 16~41%

More information

untitled

untitled 1 2 molecule Body sample pre fractionate separation processing analysis informatics Cell culture Validation Organelle fractionation Protein separation Digestion 1000 1500 2000 Mass (m/z) LC/mass spec db

More information

Hairy cell leukemia Hepatosplenic T-cell lymphoma Mycosis fungoides Sézary syndrome Lymphomatoid papulosis Primary cutaneous gd T-cell lymphoma Peripheral T-cell lymphoma, NOS Angioimmunoblastic T-cell

More information

J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN

J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN J Life Sci Res 2014; 12: 15-19 2014 Osaka Prefecture University Journal of Life Science Research Online ISSN 2186-5809 583-8555 3-7-30 577-8567 3-1-1 2014 9 11 2014 10 21 Exposure mild-level LED light

More information

180126_TOO_ウイルス感染症研究者向け資料【最終】.indd

180126_TOO_ウイルス感染症研究者向け資料【最終】.indd ウイルス 感染症研究 実験特集 不可能を可能にする NanoLuc テクノロジー NanoLuc テクノロジーをご利用のウイルス 感染症研究に携わるユーザー 4 名の方に最新の 研究成果についてご寄稿頂きました プロメガが開発した NanoLuc は 19 KDa の低分子の発光酵素であり 従来のホタルルシフェラーゼの 1/3 の分子量であるにもかかわらず 発 光レベルは 1 倍にも達します この

More information

FANCD PIG-A PIG-A é íá ñ ü de novo JAK2 AML1-EVI1NUP98-HOXD13 DEK-NUP214 FLT3 FMS RAS AML1 RUNX1 p53 RAS p15 INK4b TET2 RPS14TET2 RPS14 ë World

More information

レポート 課 題 : 次 世 代 シークエンサーが 産 出 する 大 規 模 シークエンシ ングデータを 生 命 科 学 にどう 活 かすか? というお 題 で A4レポート 用 紙 1 枚 程 度 の 文 章 ( 講 義 の 感 想 自 分 で 調 べたこと などなど)を 書 いてください 提 出

レポート 課 題 : 次 世 代 シークエンサーが 産 出 する 大 規 模 シークエンシ ングデータを 生 命 科 学 にどう 活 かすか? というお 題 で A4レポート 用 紙 1 枚 程 度 の 文 章 ( 講 義 の 感 想 自 分 で 調 べたこと などなど)を 書 いてください 提 出 2015 年 4 月 16 日 生 命 情 報 特 別 講 義 第 2 次 世 代 シークエンサーの インフォマティクス 佐 藤 健 吾 慶 應 義 塾 大 学 理 工 学 部 生 命 情 報 学 科 satoken@bio.keio.ac.jp レポート 課 題 : 次 世 代 シークエンサーが 産 出 する 大 規 模 シークエンシ ングデータを 生 命 科 学 にどう 活 かすか? というお

More information

ゲノム解読による腫瘍の理解 n どの遺伝子異常が起こる? どういった分子経路の異常が腫瘍発生に寄与するのか? n どの遺伝子異常が治療標的となりうるか? 治療法の開発 n どういったゲノム異常が起こっているのか? 発がん要因の解明と予防法の開発 2

ゲノム解読による腫瘍の理解 n どの遺伝子異常が起こる? どういった分子経路の異常が腫瘍発生に寄与するのか? n どの遺伝子異常が治療標的となりうるか? 治療法の開発 n どういったゲノム異常が起こっているのか? 発がん要因の解明と予防法の開発 2 ゲノム解析による希少がんの臨床開発 柴田龍弘 東京大学医科学研究所ゲノム医科学分野国立がん研究センター研究所がんゲノミクス研究分野 1 2016.12.9. 第 2 回希少がん対策専門部会 ゲノム解読による腫瘍の理解 n どの遺伝子異常が起こる? どういった分子経路の異常が腫瘍発生に寄与するのか? n どの遺伝子異常が治療標的となりうるか? 治療法の開発 n どういったゲノム異常が起こっているのか?

More information

/‚“1/ŒxŒ{‚×›î’æ’¶

/‚“1/ŒxŒ{‚×›î’æ’¶ 60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:

More information

Microsoft Word

Microsoft Word 理化学研究所主任研究員 石井俊輔 仲介因子を介した遺伝子発現制御の解明 1. 研究実施の概要基本構想 CBP などのコアクティベーターや N-CoR などのコリプレッサーの仲介因子はプロモーター上流のエンハンサー サイレンサーに結合する転写制御因子とコアプロモーターに結合する TBP などの基本転写因子との間のブリッジ役の分子として同定された 仲介因子はヒストンをアセチル化する酵素 (HAT: histone

More information

Untitled

Untitled 上原記念生命科学財団研究報告集, 24(2010) 164. 消化器癌におけるエピジェネティックな microrna 異常の解析 鈴木拓 Key words: 胃癌, 大腸癌,microRNA, DNA メチル化, 癌抑制遺伝子 札幌医科大学医学部内科学第一講座 緒言 microrna( 以下 mirna) は 18 ~ 22 塩基程度の短い non-coding RNA であり, 分化 増殖 アポトーシスなど細胞内の様々なプロセスに重要な役割を担っている

More information